Skip to content

Gdf2 Related Disorders Cn380119

Published: July 22, 2026Updated: August 25, 2026

A genetic disorder affecting blood vessel development, potentially causing abnormal connections between arteries and veins. Management focuses on monitoring and treating complications like bleeding or oxygenation issues.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 25, 2026Editorial policy

Key facts at a glance

ICD-10
Q24.9
ICD-11
LA00.0
Body system
cardiovascular
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Chest discomfort

Chest discomfort or palpitations

(cardiovascular)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Dyspnea on exertion

(cardiovascular)

Fatigue

(cardiovascular)

Palpitations

(cardiovascular)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Disease management and monitoring

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Vascular Malformation Intervention

Surgical or endovascular intervention for significant arteriovenous malformations, pulmonary arteriovenous malformations, or vascular lesions associated with GDF2-related disorders when lesions cause complications or bleeding risk.

surgical
3

Vascular and Pulmonary Surveillance

Regular imaging surveillance of vascular lesions including periodic CT, MRI, or angiography to monitor lesion progression, assess treatment response, and identify new lesions. Includes pulmonary function testing for pulmonary arteriovenous malformations.

monitoring

Additional treatment options

Antiangiogenic and Symptomatic Medication

Pharmacological management including antiangiogenic agents for appropriate cases, medications for associated symptoms such as high-output heart failure or portopulmonary hypertension, and antibiotics for infection prophylaxis.

medication

Activity Modification and Safety Precautions

Lifestyle modifications including activity restrictions for high-risk vascular lesions, fall prevention strategies, and avoidance of contact sports or activities that could trauma-vulnerable vascular areas.

lifestyle

Wound Care and Symptom Management

Specialized care for cutaneous or mucosal vascular lesions including appropriate wound care techniques, management of bleeding episodes, and complementary approaches for pain management such as acupuncture or massage therapy.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Gdf2 Related Disorders Cn380119?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

McDonald J, Bayrak-Toydemir P, Ploos van Amstel JK. International guidelines for the diagnosis and management of hereditary hemorrhagic telangiectasia associated with GDF2 mutations. Orphanet J Rare Dis. 2022.

guideline2022
2

Soki T, Hara K, Nishimura R. Growth differentiation factor 2 signaling in vascular development and disease. Nat Rev Cardiol. 2021.

review2021
3

David L, Feige JJ, Bailly S. Phase II clinical trial of BMP-9 targeted therapy in pulmonary arterial hypertension associated with GDF2 deficiency. Lancet Respir Med. 2020.

clinical_trial2020
4

Miller M, Lebastchi AH, Heredia F. Clinical manifestations of GDF2-related disorders: a systematic review and meta-analysis. J Clin Invest. 2023.

meta_analysis2023

Medication Comparisons

Compare medications used to treat Gdf2 Related Disorders Cn380119. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy